These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10853464)

  • 1. Exisulind shows positive results in the prevention of precancerous colon polyps.
    Oncology (Williston Park); 2000 May; 14(5):772-3. PubMed ID: 10853464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S; Halimi C; Caulin C; Bergmann JF
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exisulind Cell Pathways.
    Griffiths GJ
    Curr Opin Investig Drugs; 2000 Nov; 1(3):386-91. PubMed ID: 11249724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.
    Arber N; Kuwada S; Leshno M; Sjodahl R; Hultcrantz R; Rex D;
    Gut; 2006 Mar; 55(3):367-73. PubMed ID: 16150858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
    Stoner GD; Budd GT; Ganapathi R; DeYoung B; Kresty LA; Nitert M; Fryer B; Church JM; Provencher K; Pamukcu R; Piazza G; Hawk E; Kelloff G; Elson P; van Stolk RU
    Adv Exp Med Biol; 1999; 470():45-53. PubMed ID: 10709673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac therapy of colorectal polyps in familial adenomatous polyposis.
    Tonelli F; Valanzano R; Dolara P
    Dig Dis; 1994; 12(5):259-64. PubMed ID: 7882547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical development plan: sulindac sulfone.
    J Cell Biochem Suppl; 1996; 26():227-35. PubMed ID: 9154180
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.
    van Stolk R; Stoner G; Hayton WL; Chan K; DeYoung B; Kresty L; Kemmenoe BH; Elson P; Rybicki L; Church J; Provencher K; McLain D; Hawk E; Fryer B; Kelloff G; Ganapathi R; Budd GT
    Clin Cancer Res; 2000 Jan; 6(1):78-89. PubMed ID: 10656435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with sulindac of adenomatous polyps in familial polyposis].
    Cerdán FJ; Torres-Melero J; Martínez S; Gutiérrez del Olmo A; Balibrea JL
    Rev Esp Enferm Dig; 1995 Aug; 87(8):574-6. PubMed ID: 7577106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci.
    Kim KP; Whitehead C; Piazza G; Wargovich MJ
    Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
    Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
    Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of carcinogenesis in familial tumors.
    Ishikawa H
    Int J Clin Oncol; 2004 Aug; 9(4):299-303. PubMed ID: 15375706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
    Labayle D; Fischer D; Vielh P; Drouhin F; Pariente A; Bories C; Duhamel O; Trousset M; Attali P
    Gastroenterology; 1991 Sep; 101(3):635-9. PubMed ID: 1650315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OSI-461 (OSI).
    Galmarini CM
    Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac slows growth of colon polyps, may prevent colon cancer.
    Oncology (Williston Park); 1996 Feb; 10(2):218. PubMed ID: 8838263
    [No Abstract]   [Full Text] [Related]  

  • 16. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
    Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
    Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer pathways' target not validated by clinical results.
    Ratner M
    Nat Biotechnol; 1999 Mar; 17(3):220. PubMed ID: 10096279
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulindac and polyp regression.
    Giardiello FM
    Cancer Metastasis Rev; 1994 Dec; 13(3-4):279-83. PubMed ID: 7712590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on chemoprevention agent selection and short-term clinical prevention trials.
    Kelloff GJ; Hawk ET; Crowell JA; Boone CW; Steele VE; Lubet RA; Sigman CC
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():79-85. PubMed ID: 9061299
    [No Abstract]   [Full Text] [Related]  

  • 20. Cure crusader. How a cancer patient waged a determined quest for a medical miracle--and may still achieve it.
    Thompson D
    Time; 1999 Oct; 154(15):72-3. PubMed ID: 10620933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.